ADOPTIVE IMMUNOTHERAPY WITH ACTIVATED MARROW INFILTRATING LYMPHOCYTES AND CYCLOPHOSPHAMIDE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN PATIENTS WITH RELAPSE OF HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: